Radhika Mathur, PhD
Research interests: Glioma epigenomics
Email: radhika.mathur@ucsf.edu
Characterizing the epigenomic landscapes of low and high-grade gliomas.
2017: PhD, Biological and Biomedical Sciences, Harvard University
2012: BA, Molecular Cell Biology and Economics, UC Berkeley
2020: Andrew Parsa Young Investigator Award, Society for Neuro-Oncology
2018-2021: Ruth L. Kirschstein National Research Service Award (F32), National Institutes of Health (NIH), National Cancer Institute (NCI)
2015-2017: Ruth L. Kirschstein National Research Service Award (F31), National Institutes of Health (NIH), National Cancer Institute (NCI)
2015: Best Poster Award, Annual Postdoc and Graduate Student Retreat, Dana-Farber Cancer Institute
2015: Best Poster Award, Spring Symposium, Harvard Program In Therapeutics Science
2012: Honors, Molecular and Cell Biology, UC Berkeley
2012: High Honors, Economics, UC Berkeley
Epigenomic contributions to tumor cell heterogeneity and plasticity
Mathur R. & Costello J
Nature Genetics. 2021.
MGMT Promoter Methylation Level in Newly Diagnosed Low-Grade Glioma Is a Predictor of Hypermutation at Recurrence
Mathur, R., Zhang, Y., Grimmer, M. R., Hong, C., Zhang, M., Bollam, S., Petrecca, K., Clarke, J., Berger, M. S., Phillips, J. J., Oberheim-Bush, N. A., Molinaro, A. M., Chang, S. M., & Costello, J. F. (2020).
Neuro-oncology, noaa059. Advance online publication. https://doi.org/10.1093/neuonc/noaa059
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice
Mathur R, Alver BH, San Roman AK, Wilson BG, Wang X, Agoston AT, Park PJ, Shivdasani RA, Roberts CW.
Nat Genet. 2017 Feb;49(2):296-302. doi: 10.1038/ng.3744. Epub 2016 Dec 12.
SWI/SNF (BAF) Complexes: Guardians of the Epigenome
Mathur R, Roberts CW.
Annual Review of Cancer Biology. 2018 Mar;2:413-427. doi: 10.1016/j.pharmthera.2018.05.001. Epub 2018 May 3.
ARID1A loss in cancer: Towards a mechanistic understanding
Mathur R.
Pharmacol Ther. 2018 Oct;190:15-23. doi: 10.1016/j.pharmthera.2018.05.001. Epub 2018 May 3.